Search research articles
Contact Us
Filters
Showing results (11-20 of 303) with videos related to
Page
of 31
Sort By:
Drugs
|
February 1, 2003
Antimicrobial peptides: current status and therapeutic potential
Andreas R Koczulla, Robert Bals
Current Drug Targets
|
June 22, 2006
Antimicrobial peptides in COPD--basic biology and therapeutic applications
Robert Bals, Pieter S Hiemstra
Deutsche Medizinische Wochenschrift (1946)
|
October 5, 2016
[Alpha-1-antitrypsin deficiency - an update]
Nikolas Bernhard, Robert Bals, Sebastian Fähndrich
Plos One
|
January 3, 2008
Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival
Renat Shaykhiev, Jürgen Behr, Robert Bals
Expert Opinion on Biological Therapy
|
August 31, 2007
The role of cathelicidin and defensins in pulmonary inflammatory diseases
Christian Herr, Renat Shaykhiev, Robert Bals
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 11, 2011
Antibiotic treatment of CF lung disease: from bench to bedside
Robert Bals, Dominique Hubert, Burkhard Tümmler
Deutsche Medizinische Wochenschrift (1946)
|
February 21, 2025
[Update COPD and cardiovascular events]
Maximilian Leitner, Anna Maria Blum, Robert Bals
American Journal of Respiratory and Critical Care Medicine
|
April 6, 2002
Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection
Susanne Schaller-Bals, Andreas Schulze, Robert Bals
Respiratory Research
|
July 31, 2016
The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension
Ralf Kaiser, Christian Frantz, Robert Bals, et al.
The European Respiratory Journal
|
February 21, 2015
The innate immune function of airway epithelial cells in inflammatory lung disease
Pieter S Hiemstra, Paul B McCray, Robert Bals
Page
of 31
Search research articles
Search
Showing results (11-20 of 303) with videos related to
Sort By:
Page
of 31
Drugs
|
February 1, 2003
Antimicrobial peptides: current status and therapeutic potential
Andreas R Koczulla, Robert Bals
Current Drug Targets
|
June 22, 2006
Antimicrobial peptides in COPD--basic biology and therapeutic applications
Robert Bals, Pieter S Hiemstra
Deutsche Medizinische Wochenschrift (1946)
|
October 5, 2016
[Alpha-1-antitrypsin deficiency - an update]
Nikolas Bernhard, Robert Bals, Sebastian Fähndrich
Plos One
|
January 3, 2008
Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival
Renat Shaykhiev, Jürgen Behr, Robert Bals
Expert Opinion on Biological Therapy
|
August 31, 2007
The role of cathelicidin and defensins in pulmonary inflammatory diseases
Christian Herr, Renat Shaykhiev, Robert Bals
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 11, 2011
Antibiotic treatment of CF lung disease: from bench to bedside
Robert Bals, Dominique Hubert, Burkhard Tümmler
Deutsche Medizinische Wochenschrift (1946)
|
February 21, 2025
[Update COPD and cardiovascular events]
Maximilian Leitner, Anna Maria Blum, Robert Bals
American Journal of Respiratory and Critical Care Medicine
|
April 6, 2002
Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection
Susanne Schaller-Bals, Andreas Schulze, Robert Bals
Respiratory Research
|
July 31, 2016
The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension
Ralf Kaiser, Christian Frantz, Robert Bals, et al.
The European Respiratory Journal
|
February 21, 2015
The innate immune function of airway epithelial cells in inflammatory lung disease
Pieter S Hiemstra, Paul B McCray, Robert Bals
Page
of 31